Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.44 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.44 |
| ▸ | MMP2 | P08253 | 2/20 | 0.44 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19137803 | 1.00 | GPR84 (0.52) | GPR84FFAR1FFAR4TP53PSMD14 | |
| SCHEMBL19137792 | 1.00 | GPR84 (0.52) | GPR84FFAR1FFAR4TP53PSMD14 | |
| SCHEMBL7877198 | 1.00 | GPR84 (0.52) | GPR84FFAR1FFAR4TP53PSMD14 | |
| SCHEMBL17360989 | 1.00 | GPR84 (0.52) | GPR84FFAR1FFAR4TP53PSMD14 | |
| SCHEMBL19137807 | 1.00 | GPR84 (0.52) | GPR84FFAR1FFAR4TP53PSMD14 | |
| SCHEMBL7525608 | 1.00 | GPR84 (0.52) | GPR84FFAR1FFAR4TP53PSMD14 | |
| SCHEMBL8776490 | 1.00 | GPR84 (0.52) | GPR84FFAR1FFAR4TP53PSMD14 | |
| SCHEMBL17361029 | 1.00 | GPR84 (0.52) | GPR84FFAR1FFAR4TP53PSMD14 | |
| SCHEMBL17360998 | 1.00 | GPR84 (0.52) | GPR84FFAR1FFAR4TP53PSMD14 | |
| SCHEMBL17361003 | 1.00 | GPR84 (0.52) | GPR84FFAR1FFAR4TP53PSMD14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2740781-B1 | FOAMING COMPOSITION WITH WETTABILITY MODIFYING AND CORROSION INHIBITORY PROPERTIES FOR HIGH TEMPERATURE AND ULTRA-HIGH SALINITY | INST MEXICANO DEL PETRÓLEO (MX) | 2015-12-30 | — | — | EP | claimed |
| CN-102348448-A | Thickening additive compositions | ISP INVESTMENTS INC | 2012-02-08 | — | — | CN | claimed |
| US-20170209345-A1 | DENTAL PROSTHESIS | MITSUI CHEMICALS, INC. (JP) | 2017-07-27 | — | — | US | disclosed |
| CN-106659639-A | Dental prosthesis | 三井化学株式会社 | 2017-05-10 | — | — | CN | disclosed |
| CN-102348448-A | Thickening additive compositions | ISP INVESTMENTS INC | 2012-02-08 | — | — | CN | disclosed |
| US-4221605-A | Sulfur foam process | CHEVRON RESEARCH COMPANY (US) | 1980-09-09 | — | — | US | disclosed |
| US-4111864-A | SULFUR FOAM | CHEVRON RESEARCH COMPANY (US) | 1978-09-05 | — | — | US | disclosed |
| US-4011179-A | CONTINUOUS SULFUR FOAM PREPARATION USING POLYISOCYANATES | CHEVRON RESEARCH COMPANY (US) | 1977-03-08 | — | — | US | disclosed |
| US-3954685-A | Sulfur foam product and process | CHEVRON RESEARCH COMPANY (US) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170209345-A1 | DENTAL PROSTHESIS | CAD, OR10J3, PSMA3 | GPR84 1110/4885FFAR1 1916/4885FFAR4 2496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.